NovoNordisk’s decision to investigate its recently launched Type 2 Diabetes (T2D) drug Rybelsus (semaglutide) in a...
As the new coronavirus began to spread globally, Suntrap Life Technologies Ltd established a special research team. The ...
WuXi Biologics, a global company with leading open-access biologics technology platforms, and Bayer, have announced an a...
On December 17, the largest index provider, Morgan Stanley Capital International (MSCI) updated a report on the ESG (Env...
The Chinese University of Hong Kong (CUHK) has recently developed a fully automated, low cost and rapid microrobotic dia...
China based Harbour BioMed and Utrecht University in the Netherlands have announced that they licensed to American firm ...
Takeda Pharmaceutical Company, headquartered in Japan, has announced that it has entered into an agreement to divest a p...
BioNTech and Shanghai Fosun Pharmaceutical (Group) Co, Ltd have announced an agreement to supply Mainland China with 100...
PharmaBlock Sciences (Nanjing), Inc., a leading innovative chemistry product and service provider throughout the pharmac...
Sinovac Biotech Ltd, a leading provider of biopharmaceutical products in China, has announced that the China National Me...
Hong Kong' first makeshift hospital at the Asia World-Expo, started operations on Aug 1, and had partnere...
Sinovac Biotech Ltd, a leading provider of biopharmaceutical products in China, has announced that Sinovac Life Sciences...
Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and c...
High-end health and beauty brand SWISS REJU introduces ‘K Lipolysis’, a new non-invasive body contouring tec...
I-Mab, a global clinical-stage biopharmaceutical company based in China and the US and committed to the discovery, devel...
Antengene Corporation Limited, a clinical-stage biopharmaceutical company with integrated drug discovery, clinical devel...
US-based Pfizer, Inc. and Shanghai-based LianBio have recently announced that they have entered into a collaboration aim...
Following the release of Chemistry42 to a select group of key experts in the pharmaceutical industry in Q3 2020, In...
